Abeona Therapeutics ABEO
NASDAQ ABEO
$4.40 -0.07 (-1.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Notes Payables (2014)

Updated

Abeona Therapeutics' Notes Payables was $400,000 in Q4 2014, up 60.0% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Notes Payables (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Abeona Therapeutics 251.30 Mn -462.66 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 400,000.00
Sep 30, 2014 250,000.00
API Access

Abeona Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ABEO&period=max&api_key=YOUR_API_KEY